Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulant prophylaxis and wound complications after spinal fusion surgery
IRCT20250901067071N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of apixaban and aspirin in venous thromboembolism (VTE), sponsored by Iran University of Medical Sciences. Primary endpoints: Wound complications, Length of hospital stay and 2 more. Started Sep 2025; status: completed.
02
Drugs
apixabanaspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20250901067071N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250901067071N1.